Pharmacology Flashcards

1
Q

Mechanism of action: ACE Inhibitor

A

block conversion of AT1 to AT2 > reduced AT2 mediated vasoconstriction, sodium retention and aldosterone release > reduced blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Non pharmacological management of HTN

A
smoking cessation
improve diet
reduce alcohol consumption
regular physical exercise
weight reduction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pharmacological management of HTN: first line (drug + class + dose)

A

Ramipril 2.5-10mg PO daily (ACEI)
Amlodipine 5-10mg PO daily (CCB)
Hydrochlorothiazide 12.5-50mg PO daily (Thiazide diuretic)
Losartan 50-100mg PO daily (ARBs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pharmacological management of HTN: second line

A

Beta blocker
Spironolactone
Alpha blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Non pharmacological management of dyslipidaemia

A

Dietary modification
Regular exercise
Smoking cessation
Healthy weight range

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pharmacological management of dyslipidaemia: first line (drug + class + dose)

A

Rosuvastatin 5-10mg PO daily

more potent and fewer drug interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pharmacological management of dyslipidaemia: second line

A

Bile acid biding resins (cholestyramine)
Fibrates (fenofibrate, gemfibrozil)
Ezetimibe
Nicotinic Acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mechanism of action of statins

A

Competitively inhibit HMG-CoA reductase (enzyme in cholesterol synthesis) > reduced hepatic cholesterol synthesis > increased hepatic cholesterol uptake from blood > reduced total cholesterol, LDL, (modest) TG & small increase in HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Non pharmacological management of depression in adolescents

A

CBT
Psychoeducation and supportive counselling
Drug and alcohol councelling
Nutrition
Complementary and lifestyle interventions (exercise, relaxation techniques, sleep hygiene etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pharmacological management of depression in adolescents

A

Fluoxetine (SSRI)

10mg for first week, then 20mg (normal therapeutic dose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pharmacological management of HF

A

ACEI - Ramipril 2.5mg PO daily
Beta Blocker - metoprolol MR 23.75mg PO daily
Spironolactone - 25mg PO daily
Frusemide - 20/40mg PO daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pharmacological management of H. pylori infection

A

Triple therapy:
esomeprazole 20mg BD for 7 days
amoxicillin 1g daily PO for 7 days
clarithromycin 500mg BD for 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pharmacological management of APO

A

Frusemide IV 20-80mg stat (daily dose in IV)
Morphine IV 1-2.5mg stat
GTN subling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Long term pharmacological management of ACS

A

Aspirin 100mg daily
Clopidogrel 75mg daily
Consider: Beta Blocker (metoprolol 25mg BD)
Consider: ACE (ramipril 1.25mg daily)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pharmacological management of acute ACS

A

Morphine 5mg IV
Oxygen (to be above 94%)
Nitrates 400-800 microg/5 mins
Aspirin 300mg stat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pharmacological management of T2DM

A

Metformin SR 500mg-2g daily
+ sulfonylureas (e.g. gliclazide, glipizide)
+ SGLT2 inhibitors (e.g. empaglifozin, dapaglifozin)

17
Q

Mechanism of action of metformin

A

reduced gluconeogenesis and glycogenolysis > decreased hepatic glucose production

increased muscle insulin sensitivity and uptake of glucose

> > reduced BSL

18
Q

Mechanism of action of sulfonylureas

A

Bind to SUR receptors on pancreatic beta cells

  • blocks K+ channel
  • reduced K+ outflow
  • depolarisation
  • calcium influx
  • insulin secretion

simple: increase pancreatic insulin secretion from beta cells

19
Q

Mechanism of action of SGLT2 inhibitors

A

selectively and reversibly inhibit sodium-glucose transporter protein in proximal renal tubule > decreased reabsorption of filtered glucose > increased urinary excretion of glucose

20
Q

Pharmacological management of acute mania (bipolar)

A

Lithium 500mg BD

Olanzapine 5-10mg PO nocte

21
Q

Pharmacological prevention of VTE

A

enoxaparin 40mg once daily subcut

if ortho: consider dabigatran, apixaban etc.

22
Q

Pharmacological management of pneumonia

A

Mild: amoxicillin PO 1g TDS 5-7 days
Moderate: benzylpenicillin IV 1.2g TDS
Severe: ceftriaxone IV 1g mane + azithromycin IV 500mg mane

23
Q

Pharmacological management of depression in adults

A
SSRI 
- escitalopram 10mg PO mane
- fluoxetine 20mg PO mane
- sertraline increase to 100mg mane over a week
SNRI
- desvenlafaxine
- duloxetine
- venlafaxine
TCA
- amitriptyline, nortriptyline, imipramine
24
Q

Pharmacological management of seizures

A
  1. give supportive care
  2. treat status
    - benzo after 5 mins continuous convulsions
    - midazolam IV 10mg over 2 mins
    - sodium valproate
  3. transfer to ICU if seizure continues
25
Q

Pharmacological management of sepsis (unknown origin)

A

flucloxacillin 2g IV 6 hourly

+ gentamicin 5mg/kg IV first dose